Social Toolkit – Patient Groups & Pharmaceutical Companies

For more than a decade, PatientView has seen significant growth in the patient group movement. Patient groups are actively engaging in discussions and partnering with stakeholders across the healthcare sector.

The purpose of this social media toolkit is to support both patient groups who participated in the 2023 ‘Corporate Reputation of Pharma’ survey and pharmaceutical companies featured in the report, who want to promote the survey and its ranking results to their followers on social media platforms such as LinkedIn and X, and to the rest of the industry.

The toolkit includes social media copy and social assets, aimed at enabling participating patient groups and featured pharma companies involved in PatientView’s 2023/24 ‘Corporate Reputation of Pharma’.

For further information, please contact:

[email protected], or  [email protected]